AMPLAMIX Trademark

Trademark Overview


On Monday, July 21, 2025, a trademark application was filed for AMPLAMIX with the United States Patent and Trademark Office. The USPTO has given the AMPLAMIX trademark a serial number of 99293711. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, February 19, 2026. This trademark is owned by Taudia, Inc.. The AMPLAMIX trademark is filed in the Chemical Products, Pharmaceutical Products, and Medical Instrument Products categories with the following description:

Assays for research purposes

Medical diagnostic kits consisting primarily of probes, buffers and reagents for use in testing protein biomarkers for Alzheimer's disease, neurological conditions, auto-immune diseases, and cancer

Medical diagnostic reagents and assays for testing of bodily fluids; medical diagnostic assays for bodily fluid testing for diagnosing Alzheimer’s disease, neurological conditions, auto-immune diseases, and cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Alzheimer’s disease, neurological conditions, auto-immune diseases, and cancer
amplamix

General Information


Serial Number99293711
Word MarkAMPLAMIX
Filing DateMonday, July 21, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateThursday, February 19, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAssays for research purposes
Goods and ServicesMedical diagnostic kits consisting primarily of probes, buffers and reagents for use in testing protein biomarkers for Alzheimer's disease, neurological conditions, auto-immune diseases, and cancer
Goods and ServicesMedical diagnostic reagents and assays for testing of bodily fluids; medical diagnostic assays for bodily fluid testing for diagnosing Alzheimer’s disease, neurological conditions, auto-immune diseases, and cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Alzheimer’s disease, neurological conditions, auto-immune diseases, and cancer

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, July 21, 2025
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 21, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, July 21, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTaudia, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Carlos,, CA 94070

Trademark Events


Event DateEvent Description
Monday, July 21, 2025NEW APPLICATION ENTERED
Monday, July 21, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, November 25, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 8, 2025ASSIGNED TO EXAMINER
Monday, December 8, 2025NON-FINAL ACTION WRITTEN
Monday, December 8, 2025NON-FINAL ACTION E-MAILED
Monday, December 8, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 18, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 18, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 18, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 19, 2026APPROVED FOR PUB - PRINCIPAL REGISTER